|
Published by: Plunkett Research, Ltd.
Published: Aug. 20, 2007 - 67 Pages
Table of Contents
- Chapter 1: Major Trends Affecting the Biotech & Genetics Industry
- 1) A Short History of Biotechnology
- 2) The State of the Biotechnology Industry Today
- 3) Ethanol Use Grows Quickly
- 4) New Money Pours into Biotech Firms
- 5) Major Drug Companies Bet on Partnerships With Smaller Biotech Research Firms
- 6) From India to Singapore to China, Nations Compete Fiercely in Biotech Development
- 7) Gene Therapies and Patients’ Genetic Profiles Promise a Personalized Approach to Medicine
- 8) New Kinase Inhibitors Are Breakthrough Drugs for Cancer Treatment—Many More Will Follow
- 9) Pharmaceutical Costs Soar in U.S., Controversy over Drug Prices Rages On
- 10) Biotech Drugs Pick Up the Slack as Blockbuster Mainstream Drugs Age
- 11) Biogenerics are in Limbo in the U.S.
- 12) Breakthrough Drug Delivery Systems Evolve
- 13) Stem Cells—Controversy in the U.S. Threatens to Leave America Far Behind in the Research Race
- 14) Stem Cell Funding Trickles in the U.S. at the Federal Level While a Few States Create Funding of Their Own
- 15) Stem Cells—Therapeutic Cloning Techniques Advance
- 16) Stem Cells—A New Era of Regenerative Medicine Looms
- 17) Nanotechnology Converges with Biotech
- 18) Agricultural Biotechnology Scores Breakthroughs but Causes Controversy/Selective Breeding Offers a Compromise
- 19) Focus on Vaccines to Counter Potential Bioterror Attacks in the U.S.
- 20) Ethical Issues Abound
- 21) Technology Discussion—Genomics
- 22) Technology Discussion—Proteomics
- 23) Technology Discussion—Microarrays
- 24) Technology Discussion—DNA Chips
- 25) Technology Discussion—SNPs (“Snips”)
- 26) Technology Discussion—Combinatorial Chemistry
- 27) Technology Discussion—Synthetic Biology
- 28) Technology Discussion—Recombinant DNA
- 29) Technology Discussion—Polymerase Chain Reaction (PCR)
- Chapter 2: Biotech & Genetics Industry Statistics
- Biotech Industry Overview
- Global Biotechnology at a Glance: 2006
- Growth in Global Biotechnology: 2005-2006
- Biotechnology Financing, U.S., Europe & Canada: 2005-2006
- U.S. Biotechnology at a Glance: 2005-2006
- Quarterly Breakdown of Biotechnology Financings, U.S. & Canada: 2006
- Ernst & Young Survival Index, U.S. & Canadian Biotechnology Companies: 2005-2006
- Global Area of Biotech Crops by Country: 2006
- Total U.S. Biotechnology Patents Granted per Year by Patent Class: 1977-2005
- Plant-Derived Pharmaceuticals for the Treatment of Human Diseases that are in the Pipeline for Commercialization: 2007
- The U.S. Drug Discovery & Approval Process
- U.S. FDA Approval Times for New Drugs: 1993-2006
- U.S. FDA Approval Times for New Molecular Entities (NMEs): 1993-2006
- Domestic Biopharmaceutical R&D & R&D Abroad, PhRMA Member Companies: 1970-2006
- Domestic Biopharmaceutical R&D Breakdown, PhRMA Member Companies: 2005
- R&D By Global Geographic Area, PhRMA Member Companies: 2005
- R&D as a Percentage of U.S. Biopharmaceutical Sales, PhRMA Member Companies: 1970-2006
- U.S. Pharmaceutical R&D Spending Versus the Number of New Molecular Entity (NME) Approvals: 1993-2006
- Domestic & Foreign Pharmaceutical Sales, PhRMA Member Companies: 1970-2006
- Domestic & Foreign Pharmaceutical Sales by End Use & Customer, PhRMA Member Companies: 2005
- Generics' Share of the U.S. Drug Market by Volume: 1984-2007
- National Health Expenditure Amounts by Type of Expenditure, U.S.: Selected Calendar Years, 2001-2016
- Prescription Drug Expenditures, U.S.: 1965-2016
- U.S. Prescription Drug Expenditures, Aggregate & Per Capita Amounts, Percent Distribution: Selected Calendar Years, 2001-2016
- 20 Largest Global Pharmaceutical Companies: 2005-2006
- Research Funding for Biological Sciences, U.S. National Science Foundation: Fiscal Year 2006-2008
- Federal R&D & R&D Plant Funding for General Science & Basic Research, U.S.: Fiscal Years 2005-2007
- Employment in Life & Physical Science Occupations by Business Type, U.S.: May 2006
- Domestic Biopharmaceutical R&D Scientific, Professional, and Technical Personnel by Function, PhRMA Member Companies: 2005
AbstractThis carefully-researched report will be your ready-reference guide to the Biotechnology and Genetics Industry. Excerpted from Plunkett's Biotech and Genetics Industry Almanac 2008, this summary includes our analysis of the major trends, from the convergence of nanotechnology and biotechnology, to the biotech development race among such rising nations as India, Singapore and China, to the medical potential of personalized gene therapy. In addition, we provide statistical tables such as " Biotechnology Financing, U.S., Europe & Canada: 2005-2006" and " Total U.S. Biotechnology Patents Granted per Year by Patent Class: 1977-2005." In one handy summary, you'll get all of the data you need for strategic planning, business development, or industry analysis.
Get Full Details About This Report >>
|
|
US: 800.298.5699
Int'l: +1.240.747.3093
|
|
|
|
About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.
© MarketResearch.com 2008
|
